8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
Whether you have a compound and need to get started on your IND, or want to recruit patients quickly to get your early phase trials running or just need medical writing or biostatistical support for your programs - Veristat can help. We provide impactful solutions on both a full-service or functional service basis.
Veristat joins the discussion on insourcing and outsourcing as your company evolves. As a CMO, you are often faced with balancing the capital expenditures and resources of your organization. You must carefully determine whether to conduct your clincial trials in-house or outsourcing some or all components. Learn the options and how they may impact your organization at the panel discussion.
October 26, 2020 at 1:40 PM
Moderated by Steven Zelenkofske DO, EVP and CMO at Achillion Pharmaceuticals
Shaheen Limbada
Executive Vice President, Global Clinical Operations, Veristat
Schedule a meeting by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes. Or learn more about our capabilities.
This event is now Virtual and you can register with 10% off by using the registration discount code: VERISTAT10

8 min read
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...